Post by Admin on Nov 26, 2021 14:23:17 GMT
The Schizophrenia and Psychosis Action Alliance (S&PAA) has launched a transformational agenda to lead a “system wide” movement for change.
Are you ready to join us?
sczaction.org/donate/
We need to stop punishing brain illness and start seriously treating it. Millions of people are falling through gaps, left untreated, marginalized and dehumanized by the current systems of inadequate medical care and treatment resulting in unnecessary illness, death and unimaginable pain for so many individuals and families.
Evidence-based medical approaches exist today that aren’t being used in a timely manner. We cannot wait any longer to fix what we know is broken.
In 2021, S&PAA adopted a bold 10-year vision (Years 2022 - 2031) for life saving care, treatment policy and research.
Our Vision
Schizophrenia and psychosis spectrum disorders are universally recognized and treated as neurobiological brain illnesses
Our Mission
Create a movement for systemic change to improve care, support and equity for the millions of people living with schizophrenia and psychosis spectrum disorders
Our Areas of Strategic Focus
Promote Policy & Systems Level Change:
Support federal, state and local policies with best chances to save lives
“Reclassification” of schizophrenia from a behavioral to a medical condition
Advocate for patient rights to life sustaining treatment/services and medical professionals’ ability to treat without judicial oversight
Accelerate Disease Understanding/Treatment Access to Improve Patient/Caregiver Outcomes:
Increase schizophrenia disease awareness and understanding
Showcase treatment options and expose and eliminate barriers to care
Amplify the impact of anosognosia on care decisions and treatment options
Amplify Treatment and Research Breakthroughs:
Use "thought leadership" to reach more people
Expand patient and caregiver networks
Lead disease “Insights” applied research
Accelerate novel/breakthrough treatments
Promote medical professional training & career development
Our Work Ahead
There is an urgent need to bridge the evidence gap between accepted scientific fact and current systems of care for people living with schizophrenia and psychosis spectrum disorders. Over the months ahead, we will pursue the following activities to improve access and quality of care with the best chances to help end harmful public policy decisions and insufficient treatment options for patients.
Specifically, we will:
Conduct a global systems level analysis of "Reclassification" of schizophrenia from a behavioral to a medical condition to identify specific tactics for transforming existing barriers to treatment and care.
Serve as a catalyst in support of research which can lead to new treatments for patients with “clinical high risk” for psychosis. Learn More
Conduct and publicly share additional data-driven economic research to identify the total societal costs of SCZ in order to establish foundation of knowledge to best shape more effective public policies. Learn More
Provide support and education for those living with schizophrenia and psychosis. Register for a peer-based or caregiver support group.
Partner with industry to help ensure new therapeutics are safe, effective and have best chances for regulatory success.
We are leading a movement to improve care, support and equity for the millions of people living with schizophrenia and psychosis spectrum disorders
Are you ready to join us?
sczaction.org/donate/
We need to stop punishing brain illness and start seriously treating it. Millions of people are falling through gaps, left untreated, marginalized and dehumanized by the current systems of inadequate medical care and treatment resulting in unnecessary illness, death and unimaginable pain for so many individuals and families.
Evidence-based medical approaches exist today that aren’t being used in a timely manner. We cannot wait any longer to fix what we know is broken.
In 2021, S&PAA adopted a bold 10-year vision (Years 2022 - 2031) for life saving care, treatment policy and research.
Our Vision
Schizophrenia and psychosis spectrum disorders are universally recognized and treated as neurobiological brain illnesses
Our Mission
Create a movement for systemic change to improve care, support and equity for the millions of people living with schizophrenia and psychosis spectrum disorders
Our Areas of Strategic Focus
Promote Policy & Systems Level Change:
Support federal, state and local policies with best chances to save lives
“Reclassification” of schizophrenia from a behavioral to a medical condition
Advocate for patient rights to life sustaining treatment/services and medical professionals’ ability to treat without judicial oversight
Accelerate Disease Understanding/Treatment Access to Improve Patient/Caregiver Outcomes:
Increase schizophrenia disease awareness and understanding
Showcase treatment options and expose and eliminate barriers to care
Amplify the impact of anosognosia on care decisions and treatment options
Amplify Treatment and Research Breakthroughs:
Use "thought leadership" to reach more people
Expand patient and caregiver networks
Lead disease “Insights” applied research
Accelerate novel/breakthrough treatments
Promote medical professional training & career development
Our Work Ahead
There is an urgent need to bridge the evidence gap between accepted scientific fact and current systems of care for people living with schizophrenia and psychosis spectrum disorders. Over the months ahead, we will pursue the following activities to improve access and quality of care with the best chances to help end harmful public policy decisions and insufficient treatment options for patients.
Specifically, we will:
Conduct a global systems level analysis of "Reclassification" of schizophrenia from a behavioral to a medical condition to identify specific tactics for transforming existing barriers to treatment and care.
Serve as a catalyst in support of research which can lead to new treatments for patients with “clinical high risk” for psychosis. Learn More
Conduct and publicly share additional data-driven economic research to identify the total societal costs of SCZ in order to establish foundation of knowledge to best shape more effective public policies. Learn More
Provide support and education for those living with schizophrenia and psychosis. Register for a peer-based or caregiver support group.
Partner with industry to help ensure new therapeutics are safe, effective and have best chances for regulatory success.
We are leading a movement to improve care, support and equity for the millions of people living with schizophrenia and psychosis spectrum disorders